Marco Porcu, Pharm D
About Marco Porcu, Pharm D
Marco Porcu, Pharm D, is a Clinical Trial Manager at Novocure in Lucerne, Switzerland, specializing in Phase III oncology clinical trials.
Title
Marco Porcu serves as a Clinical Trial Manager - Global at Novocure. Based in Lucerne, Switzerland, he plays a crucial role in overseeing late-stage clinical trials in the oncology sector.
Current Role at Novocure
Marco Porcu joined Novocure in February 2021 and is currently responsible for managing Phase III oncology clinical trials. His role involves coordinating global efforts to ensure the execution and completion of these critical late-stage trials.
Educational Background
Marco Porcu earned his Doctor of Pharmacy (Pharm D) degree from Università degli Studi di Firenze. He attended the university from 1998 to 2004, where he completed a six-year master's degree program.
Clinical Trial Management
At Novocure, Marco Porcu oversees Phase III oncology clinical trials. His responsibilities include managing complex trials, ensuring regulatory compliance, and coordinating with multiple stakeholders to drive the trials towards successful outcomes.